NPNatalia Pluta

Natalia Pluta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Natalia Pluta has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Scrotal swelling: a urological emergency or a symptom of systemic disease? A case report of nephrotic syndrome

    by Wiktoria Napiórkowska, Natalia Anna Pluta, Katarzyna Mikołajczyk, Magdalena Żak, Marcin Tkaczyk, Agata BęDzichowska

    This case report describes a diagnostically challenging presentation of nephrotic syndrome in a two-year-old boy initially suspected to have testicular torsion due to prominent scrotal oedema. The case demonstrates how the characteristic features of nephrotic syndrome – generalised oedema, proteinuria, and hypoalbuminaemia – may be initially obscured by focal symptoms mimicking surgical emergencies. The patient underwent scrotal exploration for suspected appendix testis torsion based on ultrasonography findings; however, postoperative persistence of oedema and development of ascites prompted recognition of the underlying nephrotic syndrome. Prompt initiation of corticosteroid therapy led to rapid resolution of proteinuria and clinical improvement. This report contributes to the existing literature by illustrating how nephrotic syndrome may present atypically, potentially delaying diagnosis when focal symptoms dominate the clinical picture.

  • Open Access

    Gut - Brain - Ovary Axis in Polycystic Ovary Syndrome: Microbiota, Metabolic Inflammation, and Reproductive Dysfunction

    by Jakub Lech, Anna Marcinkowska, Julia Nowosielska, Karol Stobiński, Aleksandra Płusa, Natalia Pluta, Patryk Barczuk, Urszula Załuska, Weronika Kopyt, Katarzyna Latalska

    IntroductionPolycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by reproductive, metabolic, and inflammatory disturbances. Increasing evidence suggests that gut microbiota plays a significant role in the regulation of metabolic and neuroendocrine pathways involved in PCOS. AimThe aim of this review was to summarize current knowledge on the gut-brain-ovary axis in PCOS, with particular focus on the contribution of gut microbiota dysbiosis to metabolic inflammation and reproductive dysfunction. Material and methodsA narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases. Peer-reviewed articles published in English up to March 2024 were analyzed. Studies addressing associations, underlying mechanisms, and therapeutic interventions linking gut microbiota with metabolic, inflammatory, neuroendocrine, and reproductive features of PCOS were included. ResultsAvailable evidence indicates that women with PCOS exhibit significant alterations in gut microbiota composition, including reduced microbial diversity, decreased abundance of short-chain fatty acid-producing bacteria, and increased prevalence of pro-inflammatory taxa. These changes are associated with insulin resistance, impaired intestinal barrier function, metabolic endotoxemia, chronic low-grade inflammation, hyperandrogenism, and disturbances in hypothalamic-pituitary-ovarian signaling. ConclusionsGut microbiota dysbiosis appears to play an important integrative role in the pathophysiology of PCOS by linking metabolic inflammation with neuroendocrine and ovarian dysfunction. The gut-brain-ovary axis represents a promising conceptual framework and therapeutic target; however, further well-designed longitudinal and mechanistic studies are required.

  • Open Access

    Wearable Technologies in Team Sports: A Systematic Review of Their Role in Training Load Management and Injury Prevention

    by Urszula Zaluska, Simone Szymczyk, Patryk Barczuk, Natalia Pluta, Karol Stobiński, Anna Marcinkowska, Jakub Lech, Aleksandra Płusa, Weronika Kopyt, Sabina Jóźwiak

    The rapid development of wearable technologies has significantly influenced contemporary team sports by enabling advanced athlete monitoring and supporting data-driven training management. The aim of this systematic review was to evaluate the role of wearable technologies in team sports, with particular emphasis on training load monitoring, athlete performance analysis, and injury prevention. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science, and studies were selected according to predefined inclusion and exclusion criteria. The analyzed literature indicates that wearable technologies, such as global positioning systems (GPS), inertial measurement units (IMU), accelerometers, and heart rate monitors, are widely used to assess both external and internal training load. These systems enable continuous data collection on movement patterns, physiological responses, and biomechanical demands during training and competition. As a result, they support workload evaluation, facilitate individualized training programs, and enhance evidence-based decision-making. Wearable technologies also contribute to injury prevention by enabling monitoring of cumulative load and sudden changes in training intensity, which may indicate increased injury risk. However, limitations remain, including issues related to measurement validity, inter-device variability, and challenges in data interpretation. In conclusion, wearable technologies represent valuable tools for improving athlete monitoring, optimizing training processes, and supporting injury prevention in team sports. Their effectiveness depends on both device accuracy and appropriate data interpretation. Further research is needed to standardize their application across different sports and performance levels.

  • Open Access

    Effectiveness of Pharmacological Pain Management Strategies for Severe Symptoms in Endometriosis in Sport

    by Natalia Kaczmarczyk, Zofia Gołąbek, Jana Kozłowska, Simone Szymczyk, Hanna Kaczuba, Kacper Król, Klaudia Kozyra, Natalia Pluta, Weronika Kopyt

    Background. Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus, leading to severe pelvic pain, dysmenorrhea, dyspareunia, and reduced quality of life. Despite multiple therapeutic options, effective pain control remains challenging, particularly in patients with severe or recurrent disease. Aim. This study aimed to synthesize current evidence on hormonal and non-hormonal pain-management strategies for severe symptoms in endometriosis. Material and methods. A systematic literature review was conducted using PubMed, ScienceDirect, ResearchGate, and Google Scholar. Randomized controlled trials, cohort studies, and case-control studies published between 2022 and 2025 were included. Studies evaluating pain outcomes using validated pain assessment tools were eligible. Data were extracted regarding intervention type, patient characteristics, follow-up duration, pain outcomes, and risk of bias. Results. Hormonal therapies, including progestogen-based treatments, combined estrogen–progestogen regimens, and gonadotropin-suppressing agents, demonstrated effectiveness in reducing dysmenorrhea and inflammation however outcome varies by formulation, dose, and patient hormonal responsiveness.Non-hormonal approaches, such as anti-inflammatory analgesics, neuromodulatory agents, physical therapies, and multidisciplinary care, provided additional symptom relief, although responses varied considerably among patients. Treatment effectiveness was influenced by reproductive plans, tolerability, contraindications, and long-term safety. Conclusions. Hormonal therapies remain the most effective first-line option for pain reduction in patients with moderate-to-severe endometriosis who are not seeking pregnancy. Individualized, multimodal treatment strategies are essential to address symptom variability and optimize long-term outcomes.